Minaris Regenerative Medicine is a global contract development and manufacturing organization for the production of cell and gene therapy products. We offer our clients clinical and commercial manufacturing services, development solutions, and technologies.
With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies.
At Minaris, we are creating cell therapy miracles together.
Minaris Regenerative Medicine is wholly owned by Showa Denko Materials Co., Ltd.
cgmp manufacturing, cgmp commercial manufacturing, cgmp process, product, assay development, gtp cell & tissue processing & sourcing, cgmp, gtp cryostorage, regenerative medicine, cell therapy, gene therapy
Outlook, Microsoft Office 365, GoDaddy Hosting, Route 53, Hubspot, Media Temple SSL, Mobile Friendly, AddThis, Google Analytics, Visual Website Optimizer, Google Font API, WordPress.org, Google Tag Manager, Hotjar